TD Cowen Insights

TD Securities, TD Cowen
undefined
Jun 23, 2020 • 40min

Conversation With Glooko

Recorded on 06-19-20 Join us as we speak with CEO of Glooko, Russ Johannesson and discuss the future of digital diabetes care. Podcast episode hosted by Cowen's Health Care Analyst, Ryan Blicker, who covers diabetes devices, an industry with exciting long term secular growth. For Disclosures, click here bit.ly/3cPHkNW https://go.td.com/PodcastDisclosure
undefined
Jun 23, 2020 • 42min

Conversation With Evidation

Recorded on 06-18-20 In this episode, we talk about data. The explosion of data in the digital age has changed how we do just about everything, and that holds true for healthcare as well. The biopharma industry, which has always valued and sought out new forms of data has increasingly started looking outside the controlled environment of clinical trials to find data from the real world. One newer form of real-world evidence is everyday behavior data. And to help us explore this topic is Deborah Kilpatrick, CEO of Evidation Health, a new kind of health and measurement company that focuses on capturing and measuring everyday behavior data, which is proving to be an exceptionally powerful lens on health. Podcast episode hosted by Cowen's Health Care Technology Analyst Charles Rhyee. For Disclosures, click here bit.ly/3cPHkNW https://go.td.com/PodcastDisclosure
undefined
Jun 22, 2020 • 43min

Conversation With Click Therapeutics

Recorded on 06-18-20 In this episode, we continue the discussion around digital therapeutics with David Klein, co-Founder and CEO of Click Therapeutics, which develops software as a prescription medical treatment using cognitive and neurobehavioral mechanism to enable change within individuals. Podcast episode hosted by Cowen's Health Care Technology Analyst Charles Rhyee. For Disclosures, click here bit.ly/3cPHkNW https://go.td.com/PodcastDisclosure
undefined
Jun 22, 2020 • 42min

Conversation with Welldoc

In this episode, Anand Iyer, Chief Strategy Officer of Welldoc, discusses the development and outcomes of Welldoc's BlueStar, a mobile prescription therapy for type 2 diabetes. They explore the potential for reversing diabetes, improving diabetes care through technology and data analysis, and the challenges of commercializing digital therapeutics. They also touch on the opportunities for improving healthcare through digital tools and data insights.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app